Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer
Translational Research · 2026
DOI: 10.1016/j.trsl.2026.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2026. Verfasst von Sang-Pil Choi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: MafB Transcription Factor, Tumor-Associated Macrophages, Immune Checkpoint Inhibitors, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, Korea University, National Research Foundation of Korea.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains largely resistant to immune checkpoint inhibitors (ICIs) due to an immunosuppressive tumor microenvironment (TME) shaped by M2-like tumor-associated macrophages (TAMs). Identifying transcriptional regulators of M2-like TAMs in CRC could provide strategies to overcome ICI resistance by reprogramming the TME. In this study, we analyzed single-cell RNA-seq data from CRC patients to identify transcriptional regulators of M2-like TAMs. Notably, MAFB expression was predominantly detected in M2-like TAMs and was significantly higher in mismatch repair-proficient (pMMR) CRC than in mismatch repair-deficient (dMMR) CRC. Moreover, MAFB expression was inversely correlated with relapse-free survival in colon cancer patients. In macrophages, MAFB was induced by the IL-4-STAT6 and IL-10-STAT3 pathways, which drive M2 polarization, and was suppressed by M1-polarizing signals. Myeloid-specific deletion of Mafb, in combination with ICI treatment, reduced colon cancer growth by enhancing anti-tumor immunity through increased activity of M1-like TAMs, which led to increased infiltration of NK cells and activated cytotoxic T cells within the TME. Mechanistically, MAFB acts as a transcriptional activator directly promoting Il4ra, Il10, and Arg1 mRNA expression, supported by the identification of MAF recognition element (MARE) sites within these loci. Consistently, ectopic expression of IL-4 receptor α in Mafb-deficient macrophages restored M2 phenotypes comparable to those of wild-type macrophages. These data highlight the critical cell-intrinsic role of MAFB in regulating M2-like TAMs and provide the first evidence that targeting MAFB enhances ICI efficacy in CRC by reprogramming TAMs toward an anti-tumorigenic M1-like phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, School of Medicine, Baltimore, MD 21201, USA.
- Department of Urology, School of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Electronic address: tchun@korea.ac.kr.
Förderung
- Ministry of Science and ICT, South Korea
- Korea University
- National Research Foundation of Korea
Zitieren
APA
Choi, S. P., Yang, J., Park, I. B., Kang, S. J., Park, S. W., Lee, C. H., Lee, H. J., Bae, J., Choi, C. Y., Shin, J., Kim, J. I., Jin, H. Y., Lee, Y. S., & Chun, T. (2026). Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer. Translational Research. https://doi.org/10.1016/j.trsl.2026.02.006
Vancouver
Choi SP, Yang J, Park IB, Kang SJ, Park SW, Lee CH, et al. Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer. Translational Research. 2026. doi:10.1016/j.trsl.2026.02.006
BibTeX
@article{Choi2026,
author = {Choi, Sang-Pil and Yang, Jun and Park, In-Byung and Kang, Seok-Jin and Park, Si-Won and Lee, Chang-Hee and Lee, Hyeon Jeong and Bae, Joonbeom and Choi, Chang-Yong and Shin, Jiyoon and Kim, Ji-In and Jin, Hyun Yong and Lee, Young Sik and Chun, Taehoon},
title = {Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer},
journal = {Translational Research},
year = {2026},
doi = {10.1016/j.trsl.2026.02.006}
}
EUVIMED